We’re excited to see that Medicines for All Institute, having delivered huge improvements in affordability and access to a wide range of global health treatments, is now moving to secure the supply chains for essential medications in the USA. We’re very proud that Frank Gupton asked Bruce to help him prepare the original business plan for M4ALL, seek […]
We were thrilled to support this important and successful evaluation of medication monitors to support the care of self-administering TB patients.
top TB Partnership is hosting a series of “virtual innovation spotlights” to highlight promising technologies for better TB care. The first session on Qure.ai from our friend, Prashant Warier, will talk about how we can leverage AI for screening, contact tracing, and triaging for TB and COVID-19.
The Arcady Group is proud to have supported the Stop TB Partnership’s vision in transforming care models in high TB burden countries by creating the Re-imagining TB Care website.
I was honored to be invited by USAID (Dr. Amar Shah) and the WHO (Dr. Malik Parmar) to serve as Mewat Evaluation Team Leader for India’s Evaluation of Integrated Digital Adherence Technology (IDAT) For Treatment Support of TB Patients. Our team [Mr. Bruce Thomas (lead), Dr. Shanker Matta, Mr. Bharat Bhushan Dahiya, Dr. Bhavin Vadera, Dr. Srikrishna S R, Dr. Yogesh Gurav, Dr. […]
We are honored and thrilled that the Stop TB Partnership’s Strategic Initiatives and Innovative Financing (“SIIF”) team has selected The Arcady Group to provide consulting services to accelerate the roll-out of emerging technologies and digital health solutions to End TB.
Unitaid and the KNCV Tuberculosis Foundation signed a US$13.9 million grant agreement to enhance the existing evidence base, drive scaled deployment, and create market access plans and tools for digital adherence technologies to enhance TB medication adherence.